The Andrew L. Warshaw, MD Institute for Pancreatic Cancer Research recently announced $248,750 in research awards to deepen the understanding of pancreatic cancer biology.

Andrew L. Warshaw, MD Institute Announces First Research Awards


Award recipients include:

  • David Ting, MD, to study gene expression profiling of pancreatic circulating tumor cells ($15,000 award).
  • Omer Yilmaz, MD, PhD, to study in vivo characterization of olfactomedin-4 and its prognostic implications in pancreatic cancer ($57,500 award).
  • Peter Caravan, PhD, to study molecular MR imaging of the desmoplastic response in pancreatic cancer ($57,500 award).
  • Nabeel Bardeesy, MD, PhD, to develop an integrative biology approach to dissect the role of epigenetic regulators in pancreatic cancer ($50,000 award).
  • Sarah Thayer, MD, for work on genetic mapping and cloning of a novel pancreatic cancer gene ($11,250 award).
  • Kevin Haigis, PhD, to research SIRT2 regulation of the oncogenicity of mutant K-RAS ($57,500 award).



U.S. News and World Report Best Hospitals 2014-2015

U.S. News & World Report ranks Mass General #1 in New England and #2 in the nation based on our quality of care, patient safety and reputation in 16 clinical specialties.

Search the Mass General news archive

Search the archive for previously published news articles, press releases and publications.

View all departments

Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.